Automated description from the Alliance of Genome Resources (Release 7.1.0)
Predicted to enable ribosylnicotinamide kinase activity and ribosylnicotinate kinase activity. Acts upstream of or within negative regulation of myoblast differentiation. Predicted to be located in nucleoplasm and plasma membrane. Predicted to be active in cytoplasm. Is expressed in several structures, including cardiovascular system; lung; skeletal muscle tissue; and thymus. Orthologous to human NMRK2 (nicotinamide riboside kinase 2).